SCHEDULE 13G/A: Autonomix Medical: Key Investors Divest All Shares

Several investment funds and their principals have reported divesting their entire beneficial ownership in Autonomix Medical, Inc., reducing their stake to 0%.

Summary

• Cavalry Fund I LP, C/M Capital Master Fund, LP, C/M Capital Partners, LP, Mercer Street Global Opportunity Fund, LLC, Mercer Street Capital Partners, LLC, Thomas Walsh, and Jonathan Juchno (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13G.
• The Reporting Persons collectively reported 0% beneficial ownership of Autonomix Medical, Inc.'s Common Stock, par value $0.001 per share, as of the event date.
• This filing indicates a complete divestment of their previously held shares in Autonomix Medical, Inc.
• The event requiring this filing occurred on June 30, 2025, when their aggregate beneficial ownership dropped to 0%.

Sentiment

Score: 3

Explanation: The complete divestment of shares by multiple institutional investors suggests a lack of confidence or a strategic exit, which is generally viewed negatively by the market.

Positives

• NA

Negatives

• Multiple institutional investors and their principals have completely divested their beneficial ownership in Autonomix Medical, Inc., reducing their stake to 0%.

Risks

• NA

Future Outlook

NA

Industry Context

The complete divestment by multiple institutional funds is a significant event in the context of a company's investor base. While funds regularly adjust their portfolios, a full exit by several entities can be interpreted by the market as a signal regarding the company's future prospects or a shift in investment strategy by the exiting funds.

Stakeholder Impact

• Shareholders may interpret the complete divestment by institutional investors as a negative indicator, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

The complete divestment of shares by multiple institutional investors, including Cavalry Fund I LP and Mercer Street Global Opportunity Fund, LLC, indicates a significant loss of confidence or a strategic exit from Autonomix Medical, Inc. This action by sophisticated investors typically signals potential underlying issues or a belief that the stock's future performance will be unfavorable, warranting a 'sell' recommendation.

Keywords

Autonomix Medical, Common Stock, Schedule 13G, Beneficial Ownership, Divestment, Institutional Investors, Cavalry Fund I LP, Mercer Street Global Opportunity Fund, LLC, C/M Capital Master Fund, LP